Login / Signup

Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumonia.

Masahiro UeharaNoriyuki EnomotoYoshiyuki OyamaYuzo SuzukiMasato KonoKazuki FuruhashiTomoyuki FujisawaNaoki InuiYutaro NakamuraTakafumi Suda
Published in: Respirology (Carlton, Vic.) (2017)
BSA-adjusted pirfenidone dosing may be useful to prevent AE whilst achieving a long-term treatment effect in patients with IP.
Keyphrases
  • idiopathic pulmonary fibrosis
  • pulmonary fibrosis
  • intensive care unit
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation
  • replacement therapy